Every earnings call for VIMTALABS — management tone, guidance, KPIs and promise tracking, quarter by quarter.
VIMTALABS · 5 transcripts · Healthcare · latest Q4 FY26Vimta Labs has 5 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Q4 Total Income 1120 million (+17% YoY); Q4 EBITDA 421 million (+21% YoY); Q4 EBITDA Margin 37.6%. Q4 FY26 Total Income: INR1,120 million, up 16.55% YoY.
Read full transcript & analysisRevenue ₹100 cr (+10% YoY); EBITDA ₹34 cr (+0% YoY); EBITDA Margin 34.3%. Q3 FY26 Revenue of INR 100.5 crores, up 10.2% YoY.
Read full transcript & analysisEBITDA (Q2 FY26) 369 million (+21% YoY); EBITDA Margin (Q2 FY26) 35.3%; PAT (Q2 FY26) 199 million (+17% YoY). Total income for Q2 FY26 stood at INR1,045 million, up 22.3% YoY.
Read full transcript & analysisRevenue 993 million (+31% YoY); EBITDA 354 million (+33% YoY); EBITDA Margin 35.7%. Highest ever quarterly revenue of INR 993 million, up 31.4% YoY.
Read full transcript & analysisRevenue 993 million (+31% YoY); EBITDA 354 million (+33% YoY); EBITDA Margin 35.7%. Highest ever revenue of INR993 million, up 31.4% YoY.
Read full transcript & analysis